BIOTER S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.28 EUR | 0.00% |
|
+2.19% | +16.67% |
| 2023 | Bioter S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | Bioter S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1.539 | 1.322 | 0.9033 | 5.255 | 6.125 | 4.953 |
| Enterprise Value (EV) 1 | 137.5 | 144.3 | 149.9 | 163.3 | 168.9 | 177.1 |
| P/E ratio | -0.09 x | -0.1 x | -0.09 x | 0.87 x | -0.7 x | -0.51 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 8.55 x | 7.47 x | 3.61 x | 23 x | 24.9 x | 19.7 x |
| EV / Revenue | 764 x | 815 x | 600 x | 716 x | 686 x | 703 x |
| EV / EBITDA | -21.6 x | -25.6 x | -35.1 x | -80.2 x | -128 x | -132 x |
| EV / FCF | -19.3 x | -83.4 x | -58.1 x | -7.01 x | -63.7 x | -29.3 x |
| FCF Yield | -5.19% | -1.2% | -1.72% | -14.3% | -1.57% | -3.41% |
| Price to Book | -0.02 x | -0.02 x | -0.01 x | -0.06 x | -0.06 x | -0.05 x |
| Nbr of stocks (in thousands) | 16,728 | 16,728 | 16,728 | 16,735 | 16,735 | 16,735 |
| Reference price 2 | 0.0920 | 0.0790 | 0.0540 | 0.3140 | 0.3660 | 0.2960 |
| Announcement Date | 4/30/18 | 4/24/19 | 6/30/20 | 4/29/21 | 4/28/22 | 4/28/23 |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.18 | 0.177 | 0.25 | 0.228 | 0.246 | 0.252 |
| EBITDA 1 | -6.371 | -5.636 | -4.276 | -2.036 | -1.321 | -1.341 |
| EBIT 1 | -6.651 | -5.786 | -4.349 | -2.147 | -1.44 | -1.434 |
| Operating Margin | -3,695% | -3,268.93% | -1,739.6% | -941.67% | -585.37% | -569.05% |
| Earnings before Tax (EBT) 1 | -17.78 | -13.03 | -9.796 | 6.937 | -8.803 | -9.45 |
| Net income 1 | -17.52 | -12.8 | -10.29 | 6.057 | -8.809 | -9.677 |
| Net margin | -9,730.56% | -7,229.38% | -4,114.4% | 2,656.58% | -3,580.89% | -3,840.08% |
| EPS 2 | -1.047 | -0.7649 | -0.6146 | 0.3619 | -0.5264 | -0.5783 |
| Free Cash Flow 1 | -7.134 | -1.729 | -2.579 | -23.29 | -2.652 | -6.044 |
| FCF margin | -3,963.61% | -976.77% | -1,031.75% | -10,213.87% | -1,077.85% | -2,398.56% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/30/18 | 4/24/19 | 6/30/20 | 4/29/21 | 4/28/22 | 4/28/23 |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 136 | 143 | 149 | 158 | 163 | 172 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -21.34 x | -25.36 x | -34.84 x | -77.62 x | -123.2 x | -128.4 x |
| Free Cash Flow 1 | -7.13 | -1.73 | -2.58 | -23.3 | -2.65 | -6.04 |
| ROE (net income / shareholders' equity) | 28% | 16.8% | 11.5% | -6.51% | 9.54% | 9.5% |
| ROA (Net income/ Total Assets) | -4.6% | -4.1% | -3.14% | -1.54% | -1.05% | -1.06% |
| Assets 1 | 380.8 | 312.4 | 327.5 | -393.6 | 836.8 | 916.9 |
| Book Value Per Share 2 | -4.270 | -5.080 | -5.680 | -5.240 | -5.770 | -6.340 |
| Cash Flow per Share 2 | 0.0200 | 0.0100 | 0.0200 | 0.0200 | 0.0400 | 0.0400 |
| Capex 1 | 0.02 | - | - | - | 0.05 | - |
| Capex / Sales | 9.44% | - | - | - | 20.33% | - |
| Announcement Date | 4/30/18 | 4/24/19 | 6/30/20 | 4/29/21 | 4/28/22 | 4/28/23 |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +16.67% | 5M | |
| -2.73% | 67.67B | |
| +3.03% | 59.37B | |
| +22.44% | 38.3B | |
| +13.31% | 30.73B | |
| +2.60% | 26.35B | |
| +20.60% | 22.01B | |
| +14.87% | 19.47B | |
| +23.28% | 17.6B | |
| +69.16% | 16.64B |
- Stock Market
- Equities
- BIOT Stock
- Financials Bioter S.A.
